ConductScience.org, home

Paper37597697

Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents.

Johns AC and 4 others. Bioorg Med Chem Lett, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. Papers, record 37597697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37597697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents.
PubMed
Journal
Bioorg Med Chem Lett
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2025-01-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johns ACAndrew C
2Oviedo AAlejandro
3Zhao ZZhenze
4Du LLiqin
5Kornienko AAlexander

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeuroblastomaMajor topic
Antineoplastic AgentsMajor topic
Humans
Cell Differentiation
Gene Library
Neuronal Outgrowth

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R15 CA213199NCI NIH HHSUnited StatesR15CA213199PubMed and NIHNIH RePORTER
R15 CA227680NCI NIH HHSUnited StatesR15CA227680PubMed and NIHNIH RePORTER
R25 GM102783NIGMS NIH HHSUnited StatesR25GM102783PubMedNIH RePORTER

Download CSV of grants

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131202802Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.Eur J Pharmacol2019https://conductscience.org/library/papers/31202802PubMed
29046328Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors.J Med Chem1997https://conductscience.org/library/papers/9046328PubMed
329018329CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.Front Mol Neurosci2017https://conductscience.org/library/papers/29018329PubMed
45545265Differentiation of malignant to benign cells.Cancer Res1971https://conductscience.org/library/papers/5545265PubMed
524811707A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation.Oncotarget2014https://conductscience.org/library/papers/24811707PubMed
610519894Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.N Engl J Med1999https://conductscience.org/library/papers/10519894PubMed
711668484Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells.Int J Cancer2001https://conductscience.org/library/papers/11668484PubMed
831404492Novel Endogenous Ligands of Aryl Hydrocarbon Receptor Mediate Neural Development and Differentiation of Neuroblastoma.ACS Chem Neurosci2019https://conductscience.org/library/papers/31404492PubMed
93685979Tumor cell rejection through terminal cell differentiation.Science1987https://conductscience.org/library/papers/3685979PubMed
1025872738Synthetic small molecules that induce neuronal differentiation in neuroblastoma and fibroblast cells.Mol Biosyst2015https://conductscience.org/library/papers/25872738PubMed
1130719816IRE1α is critical for Kaempferol-induced neuroblastoma differentiation.FEBS J2019https://conductscience.org/library/papers/30719816PubMed
1218607002Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18607002PubMed
1331689507Differentiation of human neuroblastoma cell line IMR-32 by sildenafil and its newly discovered analogue IS00384.Cell Signal2020https://conductscience.org/library/papers/31689507PubMed
1428891114Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells.Mol Nutr Food Res2017https://conductscience.org/library/papers/28891114PubMed
151850498Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).N Engl J Med1991https://conductscience.org/library/papers/1850498PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37597697

GET https://conductscience.org/api/papers/v1/37597697/authors